Related Experiment Videos
Epidermal growth factor receptor not equal to nerve growth factor
1CNS Diseases Research, Upjohn Company, Kalamazoo, MI 49001.
Neurobiology of Aging
|September 1, 1989
Summary
This study clarifies that neurite promoting factors, not neurotrophic factors, are implicated in Alzheimer's disease research. Misidentifying these agents could worsen dementia by increasing neuronal death.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Neurotrophic factors are crucial for neuronal survival and function.
- Alzheimer's disease is characterized by progressive neurodegeneration.
- Current research explores therapeutic targets for Alzheimer's disease.
Purpose of the Study:
- To critically evaluate the definition and role of neurotrophic factors in Alzheimer's disease.
- To differentiate between neurotrophic factors and neurite promoting factors.
- To assess the potential consequences of using neurotrophic factor antagonists in Alzheimer's treatment.
Main Methods:
- Literature review and conceptual analysis.
- Examination of existing research on neurotrophic factors and Alzheimer's disease.
- Analysis of the proposed therapeutic strategies involving NGF antagonists.
Main Results:
- The study identifies a mischaracterization of agents as neurotrophic factors when they function as neurite promoting factors.
- It is argued that NGF antagonists may not be suitable for Alzheimer's disease treatment.
- Such treatment could potentially lead to increased neuronal death.
Conclusions:
- Accurate definition and differentiation of neurotrophic and neurite promoting factors are essential.
- The use of NGF antagonists in Alzheimer's disease may have detrimental effects on neuronal survival.
- Further research is needed to clarify the precise roles of these factors in neurodegenerative diseases.